TuDiabetes Live Interview Dr. Carla Greenbaum, Director of the T1D Exchange Bioban


Carla J. Greenbaum, M.D., is a Member of the Benaroya Research Institute, where she serves as the Director of the BRI Diabetes Program and the Clinical Research Center, and is on the Institutional Review Board. She received her undergraduate and medical degrees at Brown University and completed her endocrinology fellowship at the University of Washington. Dr. Greenbaum is a clinical investigator with a focus on the natural history of type 1 diabetes, specifically with prediction of disease and interventions to alter immune mediated beta cell function. She has conducted studies evaluating beta cell function and other physiologic and immune changes that occur during the progression of the natural history of type 1 diabetes.
In addition to clinical trials, she works to facilitate translational research initiatives locally and nationally. Her considerable expertise includes clinical trial design and implementation, and evaluation of biomarkers for disease course and response to therapy. She currently serves as Vice-Chair of Type 1 Diabetes TrialNet, an NIH sponsored international consortium to conduct multiple clinical trials in type 1 diabetes and will assume the position of Chair in 2015. In addition she heads up the HUB project, designed to work collaboratively with the Chairman’s office, clinical sites and the TNCC to identify and implement sustainable and scalable processes and improvements within the TrialNet consortium and is the PI for the Northwest Clinical Site. In this role, she is responsible for protocol development and clinical issues study wide. She is also involved with clinical trials with the NIH sponsored Immune Tolerance Network and the Diabetes Vaccine Development Center in Australia, as well as Phase I/II pharmaceutical trials.
She was appointed director of the Biobank Operations Center of the T1D Exchange, a national consortium sponsored by the Helmsley Trust. This registry and repository will facilitate the use of biological samples from T1D patients by qualified investigators in industry and academia.
Dr. Greenbaum is a member of the University of Washington’s CTSA leadership group. She serves on various national and international scientific review committees focusing on clinical and translational research. Currently, Dr. Greenbaum is on the Board of Directors of the Benaroya Research Institute.

Category: Nonprofits & Activism
Uploaded by: Diabetes Hands Foundation
Hosted: youtube

Below Content Ad